{
  "table_name": "BMT_GVHD_DRUGS",
  "description": "The list of drugs to be used for graft vs. host disease (GVHD) prophylaxis.",
  "primary_key": {
    "column_name": "REGIMEN_ID",
    "ordinal_position": "1"
  },
  "columns": [
    {
      "index": 2,
      "name": "REGIMEN_ID",
      "type": "NUMERIC",
      "discontinued": false,
      "description": "The unique identifier for the blood and marrow transplant treatment regimen."
    },
    {
      "index": 7,
      "name": "CONTACT_DATE_REAL",
      "type": "FLOAT",
      "discontinued": false,
      "description": "A unique contact date in decimal format. The integer portion of the number indicates the date of contact. The digits after the decimal distinguish different contacts on the same date and are unique for each contact on that date. For example, .00 is the first/only contact, .01 is the second contact, etc."
    },
    {
      "index": 12,
      "name": "LINE",
      "type": "INTEGER",
      "discontinued": false,
      "description": "The line number for the information associated with this contact. Multiple pieces of information can be associated with this contact."
    },
    {
      "index": 17,
      "name": "CONTACT_DT",
      "type": "DATETIME",
      "discontinued": false,
      "description": "The date of this contact in calendar format."
    },
    {
      "index": 22,
      "name": "GVHD_DRUG_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "The graft versus host disease drugs to use\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nTacrolimus\n\n\nCyclosporine\n\n\nMycophenolate mofetil\n\n\nSirolimus\n\n\nMethotrexate\n\n\nALG/ALS/ATG/ATS\n\n\nECP\n\n\nEtanercept\n\n\nAlemtuzumab\n\n\nIn vivo immunotoxin\n\n\nInfliximab\n\n\nCyclophosphamide\n\n\nAnti CD25\n\n\nOther agent\n\n\nIn vivo monoclonal antibody\n\n\nBlinded randomized trial\n\n\nCorticosteroids (systemic)\n\n\nEverolimus"
    }
  ]
}
